US37733W2044 - ADR - After market: 28.66 0 (0%)
Investors looking for growth stocks to buy that are largely immune from broader economic woes have come to the right place.
Spero Therapeutics (SPRO) stock is rocketing higher on Thursday after the company signed a licensing agreement with GSK (GSK).
It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.
These biotech stocks should deliver big gains to long-term investors who purchase shares at a discount during the bear market.
Pharmaceuticals are subject to whiplash trade. That's evident with sharp moves lower in Sanofi, GSK and Teva on news about clinical trials and legal actions.
Shares extended deep losses following a Zantac-inspired downturn last week.